Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors.

MLA

Chenzhou Hao, et al. “Structure-Based Design of 6-Chloro-4-Aminoquinazoline-2-Carboxamide Derivatives as Potent and Selective P21-Activated Kinase 4 (PAK4) Inhibitors.” Journal of Medicinal Chemistry, vol. 61, no. 1, Jan. 2018, pp. 265–85. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.7b01342.

APA

Chenzhou Hao, Fan Zhao, Hongyan Song, Jing Guo, Xiaodong Li, Xiaolin Jiang, Ran Huan, Shuai Song, Qiaoling Zhang, Ruifeng Wang, Kai Wang, Yu Pang, Tongchao Liu, Tianqi Lu, Wanxu Huang, Jian Wang, Bin Lin, Zhonggui He, Haitao Li, & Feng Li. (2018). Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors. Journal of Medicinal Chemistry, 61(1), 265–285. https://doi.org/10.1021/acs.jmedchem.7b01342

Chicago

Chenzhou Hao, Fan Zhao, Hongyan Song, Jing Guo, Xiaodong Li, Xiaolin Jiang, Ran Huan, et al. 2018. “Structure-Based Design of 6-Chloro-4-Aminoquinazoline-2-Carboxamide Derivatives as Potent and Selective P21-Activated Kinase 4 (PAK4) Inhibitors.” Journal of Medicinal Chemistry 61 (1): 265–85. doi:10.1021/acs.jmedchem.7b01342.